Rehmann Capital Advisory Group - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rehmann Capital Advisory Group ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$3,992,000
+34.3%
1,1090.0%0.00%
Q2 2019$2,972,000
-9.4%
1,1090.0%0.00%
Q1 2019$3,282,000
+86.2%
1,1090.0%0.00%
Q4 2018$1,763,000
-56.8%
1,1090.0%0.00%
-100.0%
Q3 2018$4,081,000
+30.1%
1,1090.0%0.00%
Q2 2018$3,138,000
+78350.0%
1,1090.0%0.00%
-100.0%
Q1 2018$4,0001,1090.00%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders